Leopold Muller Arthritis Research Centre, Institute for Science and Technology in Medicine, Medical School, Keele University, RJAH Orthopaedic Hospital, Oswestry, UK.
Cytotherapy. 2012 Oct;14(9):1080-8. doi: 10.3109/14653249.2012.700704. Epub 2012 Jul 19.
Mesenchymal stromal cells (MSC) are pluripotent adult stem cells capable of osteogenesis and chondrogenesis to form bone and cartilage. This characteristic gives them the potential for bone and cartilage regeneration. Synthetic polymers have been studied to examine whether they could be used as a scaffold for tissue engineering. In the current study a two-dimensional (2-D) poly(l-lactic acid) (PLLA) scaffold was treated with chemokine, adhesion and extracellular matrix molecules with the aim of using biologic molecules to improve the attachment of human MSC.
MSC were isolated from human bone marrow and applied to a 2-D PLLA scaffold. Chemokines ligand (CXCL12 and CXCL13), adhesion molecules [P-selectin, vascular cell adhesion molecule (VCAM)-1 and heparin] and extracellular matrix molecules (fibronectin and type IV collagen) were coated on the scaffold and their effects on the number of MSC that adhered were recorded.
When used alone CXCL12 and CXCL13 enhanced MSC adhesion, as did VCAM-1, P-selectin, fibronectin and collagen, but not heparin. The effects of VCAM-1, P-selectin and heparin were enhanced by the addition of CXCL12. Incubation of MSC with antibodies to integrins α4 and α5β1 inhibited their adhesion to VCAM-1 and fibronectin-treated PLLA respectively, suggesting that these integrins were involved in the MSC interactions.
The use of certain chemokines and adhesion and extracellular matrix molecules, alone or in combination, is beneficial for the attachment of MSC to PLLA, and may be helpful as natural molecules in scaffolds for regenerative medicine.
间充质基质细胞(MSC)是多能成体干细胞,能够成骨和成软骨,形成骨和软骨。这一特性使它们具有骨和软骨再生的潜力。合成聚合物已被研究,以检查它们是否可用于组织工程的支架。在本研究中,二维(2-D)聚(L-丙交酯)(PLLA)支架用趋化因子、黏附分子和细胞外基质分子进行处理,目的是使用生物分子来改善人 MSC 的附着。
MSC 从人骨髓中分离出来,并应用于 2-D PLLA 支架。趋化因子配体(CXCL12 和 CXCL13)、黏附分子[P-选择素、血管细胞黏附分子(VCAM)-1 和肝素]和细胞外基质分子(纤连蛋白和 IV 型胶原蛋白)涂覆在支架上,并记录其对附着的 MSC 数量的影响。
单独使用时,CXCL12 和 CXCL13 增强了 MSC 的黏附能力,VCAM-1、P-选择素、纤连蛋白和胶原蛋白也是如此,但肝素则不然。CXCL12 的加入增强了 VCAM-1、P-选择素和肝素的作用。将 MSC 与整合素 α4 和 α5β1 的抗体孵育,分别抑制了它们对 VCAM-1 和纤连蛋白处理的 PLLA 的黏附,表明这些整合素参与了 MSC 的相互作用。
单独或联合使用某些趋化因子、黏附分子和细胞外基质分子有利于 MSC 附着到 PLLA 上,并且可能有助于作为再生医学支架中的天然分子。